141-30-0,MFCD00006466
Catalog No.:AA001FMT

141-30-0 | 3,6-Dichloropyridazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25g
98%
in stock  
$10.00   $7.00
- +
100g
98%
in stock  
$13.00   $9.00
- +
500g
98%
in stock  
$55.00   $38.00
- +
1kg
98%
in stock  
$108.00   $75.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001FMT
Chemical Name:
3,6-Dichloropyridazine
CAS Number:
141-30-0
Molecular Formula:
C4H2Cl2N2
Molecular Weight:
148.9781
MDL Number:
MFCD00006466
SMILES:
Clc1ccc(nn1)Cl
NSC Number:
54498
Properties
Properties
 
BP:
277 °C at 760mmHg  
Form:
Solid  
MP:
65-69 °C  
Refractive Index:
1.6300 (estimate)  
Solubility:
0.0012g/l  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
68.4  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.7  

Upstream Synthesis Route

[1]JournalofMedicinalChemistry,2004,vol.47,#19,p.4716-4730

[1]Patent:WO2013/59587,2013,A1,.Locationinpatent:Page/Pagecolumn74;75

[2]Patent:EP2768509,2017,B1,.Locationinpatent:Paragraph0237;0238

[3]JournalofHeterocyclicChemistry,2013,vol.50,#5,p.1165-1173

[4]OrganicandBiomolecularChemistry,2010,vol.8,#18,p.4131-4136

[5]Patent:WO2007/26623,2007,A1,.Locationinpatent:Page/Pagecolumn6-7

[6]Patent:WO2007/26623,2007,A1,.Locationinpatent:Page/Pagecolumn7

[7]Patent:WO2008/88881,2008,A1,.Locationinpatent:Page/Pagecolumn32

[8]Patent:WO2012/48258,2012,A2,.Locationinpatent:Page/Pagecolumn28

[9]Patent:WO2012/48259,2012,A2,.Locationinpatent:Page/Pagecolumn35

[10]Patent:TW2016/2107,2016,A,.Locationinpatent:Paragraph0079;0080

[11]Patent:WO2009/154769,2009,A1,.Locationinpatent:Page/Pagecolumn33

[12]Patent:WO2007/26623,2007,A1,.Locationinpatent:Page/Pagecolumn6

[13]Synthesis(Germany),2014,vol.46,#7,p.947-954

[14]JournaloftheAmericanChemicalSociety,2017,vol.139,#24,p.8267-8276

[15]EuropeanJournalofMedicinalChemistry,2015,vol.105,p.80-105

[16]JournalofOrganicChemistry,1984,vol.49,#12,p.2240-2245

[17]Patent:US2009/163489,2009,A1,.Locationinpatent:Page/Pagecolumn19

[18]JournalofHeterocyclicChemistry,2002,vol.39,#1,p.173-177

[19]JournalofAgriculturalandFoodChemistry,2009,vol.57,#14,p.6356-6361

[20]EuropeanJournalofMedicinalChemistry,2015,vol.95,p.277-301

[21]Patent:WO2009/98144,2009,A1,.Locationinpatent:Page/Pagecolumn68

[22]Patent:US2010/222325,2010,A1,.Locationinpatent:Page/Pagecolumn93

[23]Patent:US2010/261727,2010,A1,.Locationinpatent:Page/Pagecolumn31-32

[24]Patent:WO2015/78836,2015,A1,.Locationinpatent:Page/Pagecolumn54

[25]JournalofMedicinalChemistry,1981,vol.24,#1,p.59-63

[26]JournaloftheAmericanChemicalSociety,1954,vol.76,p.3225

[27]HelveticaChimicaActa,1954,vol.37,p.121,131

[28]JournalofMedicinalChemistry,2006,vol.49,#14,p.4409-4424

[29]Patent:WO2009/29625,2009,A1,.Locationinpatent:Page/Pagecolumn77-78

[30]ACSMedicinalChemistryLetters,2010,vol.1,#2,p.80-84

[1]JournalofAgriculturalandFoodChemistry,2009,vol.57,#14,p.6356-6361

[2]HelveticaChimicaActa,2002,vol.85,#7,p.2195-2213

[3]JournaloftheAmericanChemicalSociety,1951,vol.73,p.1873

[4]YakugakuZasshi,1955,vol.75,p.778,780

[5]Chem.Abstr.,1956,p.4970

[6]EuropeanJournalofMedicinalChemistry,2017,vol.133,p.36-49

[7]Patent:US2671086,1951,,

[8]Patent:US2671086,1951,,

[1]ChemicalandPharmaceuticalBulletin,1998,vol.46,#10,p.1656-1657

[1]JournaloftheChemicalSociety,PerkinTransactions2:PhysicalOrganicChemistry(1972-1999),1986,p.1255-1258

[2]Patent:US3946000,1976,A,

[3]Patent:US3946000,1976,A,

Downstream Synthesis Route

[1]Tetrahedron,2015,vol.71,p.4859-4867

[2]JournalofOrganicChemistry,2013,vol.78,p.370-379

[3]EuropeanJournalofMedicinalChemistry,2015,vol.95,p.277-301

[4]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1954,vol.74,p.1195,1197    Chem.Abstr.,1955,p.14768

[5]JournalofHeterocyclicChemistry,2017,vol.54,p.2935-2945

[1]PharmaceuticalBulletin,1957,vol.5,p.376,377    PharmaceuticalBulletin,1958,vol.6,p.641

[1]OrganicandBiomolecularChemistry,2008,vol.6,p.175-186

[2]BioorganicandMedicinalChemistry,2017,vol.25,p.3649-3657

[3]OrganicLetters,2011,vol.13,p.272-275

[4]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.1226-1229

[5]Patent:WO2007/8144,2007,A1.Locationinpatent:Page/Pagecolumn31

[6]Patent:WO2011/15629,2011,A1.Locationinpatent:Page/Pagecolumn68

[7]Patent:CN109280032,2019,A.Locationinpatent:Paragraph0124-0127

[8]Patent:WO2005/65688,2005,A1.Locationinpatent:Page/Pagecolumn20

[9]ArkivfoerKemi,1959,vol.14,p.419,421

[10]PharmaceuticalBulletin,1937,vol.5,p.376,378

[11]JournaloftheAmericanChemicalSociety,1959,vol.81,p.6511,6512

[12]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1956,vol.76,p.1293,1295    Chem.Abstr.,1957,p.6645

[1]JournalofOrganicChemistry,1959,vol.24,p.811

[1]Heterocycles,1994,vol.38,p.125-134

Literature

Title: 6-Chloro-3-(3-methyl-phen-yl)-1,2,4-triazolo[4,3-b]pyridazine.

Journal: Acta crystallographica. Section E, Structure reports online 20111001

Title: S,S'-(Pyridazine-3,6-di-yl)dithio-uronium dichloride methanol monosolvate.

Journal: Acta crystallographica. Section E, Structure reports online 20110601

Title: 3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine.

Journal: Acta crystallographica. Section E, Structure reports online 20100301

Title: 3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

Journal: Acta crystallographica. Section E, Structure reports online 20100101

Title: Efficient mono- and bis-functionalization of 3,6-dichloropyridazine using (tmp)2Zn.2MgCl2.2LiCl.

Journal: Chemical communications (Cambridge, England) 20081221

Title: Solid-phase syntheses of 6-arylpyridazin-3(2H)-ones.

Journal: Journal of combinatorial chemistry 20050101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 141-30-0
Tags:141-30-0 Molecular Formula|141-30-0 MDL|141-30-0 SMILES|141-30-0 3,6-Dichloropyridazine
Catalog No.: AA001FMT
141-30-0,MFCD00006466
141-30-0 | 3,6-Dichloropyridazine
Pack Size: 25g
Purity: 98%
in stock
$10.00 $7.00
Pack Size: 100g
Purity: 98%
in stock
$13.00 $9.00
Pack Size: 500g
Purity: 98%
in stock
$55.00 $38.00
Pack Size: 1kg
Purity: 98%
in stock
$108.00 $75.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001FMT
Chemical Name: 3,6-Dichloropyridazine
CAS Number: 141-30-0
Molecular Formula: C4H2Cl2N2
Molecular Weight: 148.9781
MDL Number: MFCD00006466
SMILES: Clc1ccc(nn1)Cl
NSC Number: 54498
Properties
BP: 277 °C at 760mmHg  
Form: Solid  
MP: 65-69 °C  
Refractive Index: 1.6300 (estimate)  
Solubility: 0.0012g/l  
Storage: Keep in dry area;Room Temperature;  
Complexity: 68.4  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 8  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.7  
Upstream Synthesis Route
141-30-0    124-41-4    19064-65-4 

[1]JournalofMedicinalChemistry,2004,vol.47,#19,p.4716-4730

141-30-0    5469-69-2 

[1]Patent:WO2013/59587,2013,A1,.Locationinpatent:Page/Pagecolumn74;75

[2]Patent:EP2768509,2017,B1,.Locationinpatent:Paragraph0237;0238

[3]JournalofHeterocyclicChemistry,2013,vol.50,#5,p.1165-1173

[4]OrganicandBiomolecularChemistry,2010,vol.8,#18,p.4131-4136

[5]Patent:WO2007/26623,2007,A1,.Locationinpatent:Page/Pagecolumn6-7

[6]Patent:WO2007/26623,2007,A1,.Locationinpatent:Page/Pagecolumn7

[7]Patent:WO2008/88881,2008,A1,.Locationinpatent:Page/Pagecolumn32

[8]Patent:WO2012/48258,2012,A2,.Locationinpatent:Page/Pagecolumn28

[9]Patent:WO2012/48259,2012,A2,.Locationinpatent:Page/Pagecolumn35

[10]Patent:TW2016/2107,2016,A,.Locationinpatent:Paragraph0079;0080

[11]Patent:WO2009/154769,2009,A1,.Locationinpatent:Page/Pagecolumn33

[12]Patent:WO2007/26623,2007,A1,.Locationinpatent:Page/Pagecolumn6

[13]Synthesis(Germany),2014,vol.46,#7,p.947-954

[14]JournaloftheAmericanChemicalSociety,2017,vol.139,#24,p.8267-8276

[15]EuropeanJournalofMedicinalChemistry,2015,vol.105,p.80-105

[16]JournalofOrganicChemistry,1984,vol.49,#12,p.2240-2245

[17]Patent:US2009/163489,2009,A1,.Locationinpatent:Page/Pagecolumn19

[18]JournalofHeterocyclicChemistry,2002,vol.39,#1,p.173-177

[19]JournalofAgriculturalandFoodChemistry,2009,vol.57,#14,p.6356-6361

[20]EuropeanJournalofMedicinalChemistry,2015,vol.95,p.277-301

[21]Patent:WO2009/98144,2009,A1,.Locationinpatent:Page/Pagecolumn68

[22]Patent:US2010/222325,2010,A1,.Locationinpatent:Page/Pagecolumn93

[23]Patent:US2010/261727,2010,A1,.Locationinpatent:Page/Pagecolumn31-32

[24]Patent:WO2015/78836,2015,A1,.Locationinpatent:Page/Pagecolumn54

[25]JournalofMedicinalChemistry,1981,vol.24,#1,p.59-63

[26]JournaloftheAmericanChemicalSociety,1954,vol.76,p.3225

[27]HelveticaChimicaActa,1954,vol.37,p.121,131

[28]JournalofMedicinalChemistry,2006,vol.49,#14,p.4409-4424

[29]Patent:WO2009/29625,2009,A1,.Locationinpatent:Page/Pagecolumn77-78

[30]ACSMedicinalChemistryLetters,2010,vol.1,#2,p.80-84

123-33-1    141-30-0 

[1]JournalofAgriculturalandFoodChemistry,2009,vol.57,#14,p.6356-6361

[2]HelveticaChimicaActa,2002,vol.85,#7,p.2195-2213

[3]JournaloftheAmericanChemicalSociety,1951,vol.73,p.1873

[4]YakugakuZasshi,1955,vol.75,p.778,780

[5]Chem.Abstr.,1956,p.4970

[6]EuropeanJournalofMedicinalChemistry,2017,vol.133,p.36-49

[7]Patent:US2671086,1951,,

[8]Patent:US2671086,1951,,

25974-26-9    141-30-0 

[1]ChemicalandPharmaceuticalBulletin,1998,vol.46,#10,p.1656-1657

123-33-1    141-30-0 

[1]JournaloftheChemicalSociety,PerkinTransactions2:PhysicalOrganicChemistry(1972-1999),1986,p.1255-1258

[2]Patent:US3946000,1976,A,

[3]Patent:US3946000,1976,A,

Downstream Synthesis Route
110-89-4    141-30-0    1722-11-8 

[1]Tetrahedron,2015,vol.71,p.4859-4867

[2]JournalofOrganicChemistry,2013,vol.78,p.370-379

[3]EuropeanJournalofMedicinalChemistry,2015,vol.95,p.277-301

[4]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1954,vol.74,p.1195,1197    Chem.Abstr.,1955,p.14768

[5]JournalofHeterocyclicChemistry,2017,vol.54,p.2935-2945

141-30-0    64-19-7    19064-67-6 

[1]PharmaceuticalBulletin,1957,vol.5,p.376,377    PharmaceuticalBulletin,1958,vol.6,p.641

141-30-0    19064-67-6 

[1]OrganicandBiomolecularChemistry,2008,vol.6,p.175-186

[2]BioorganicandMedicinalChemistry,2017,vol.25,p.3649-3657

[3]OrganicLetters,2011,vol.13,p.272-275

[4]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.1226-1229

[5]Patent:WO2007/8144,2007,A1.Locationinpatent:Page/Pagecolumn31

[6]Patent:WO2011/15629,2011,A1.Locationinpatent:Page/Pagecolumn68

[7]Patent:CN109280032,2019,A.Locationinpatent:Paragraph0124-0127

[8]Patent:WO2005/65688,2005,A1.Locationinpatent:Page/Pagecolumn20

[9]ArkivfoerKemi,1959,vol.14,p.419,421

[10]PharmaceuticalBulletin,1937,vol.5,p.376,378

[11]JournaloftheAmericanChemicalSociety,1959,vol.81,p.6511,6512

[12]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1956,vol.76,p.1293,1295    Chem.Abstr.,1957,p.6645

123-33-1    141-30-0    19064-67-6 

[1]JournalofOrganicChemistry,1959,vol.24,p.811

141-30-0    326-62-5    154419-42-8 

[1]Heterocycles,1994,vol.38,p.125-134

Literature fold

Title: 6-Chloro-3-(3-methyl-phen-yl)-1,2,4-triazolo[4,3-b]pyridazine.

Journal: Acta crystallographica. Section E, Structure reports online20111001

Title: S,S'-(Pyridazine-3,6-di-yl)dithio-uronium dichloride methanol monosolvate.

Journal: Acta crystallographica. Section E, Structure reports online20110601

Title: 3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine.

Journal: Acta crystallographica. Section E, Structure reports online20100301

Title: 3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

Journal: Acta crystallographica. Section E, Structure reports online20100101

Title: Efficient mono- and bis-functionalization of 3,6-dichloropyridazine using (tmp)2Zn.2MgCl2.2LiCl.

Journal: Chemical communications (Cambridge, England)20081221

Title: Solid-phase syntheses of 6-arylpyridazin-3(2H)-ones.

Journal: Journal of combinatorial chemistry20050101

Building Blocks More >
141396-28-3
141396-28-3
Argatroban monohydrate
AA001G9N | MFCD00895735
1416367-04-8
1416367-04-8
3-Methanesulfinylphenylboronic acid, pinacol ester
AA001GOD | MFCD18733605
1417793-19-1
1417793-19-1
3-Methylthio-azetidine hydrochloride
AA001H0I | MFCD17015916
142031-67-2
142031-67-2
Methyl 4-bromo-3-(bromomethyl)benzoate
AA001HJ5 | MFCD11858300
1422344-12-4
1422344-12-4
2-(Difluoromethyl)aniline hydrochloride
AA001HXX | MFCD23378513
143851-98-3
143851-98-3
4-Acridinecarboxamide, N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-, hydrochloride (1:1)
AA001IEJ | MFCD11040791
144085-23-4
144085-23-4
Boc-(r)-alpha-allyl-proline
AA001ITX | MFCD01076221
14440-47-2
14440-47-2
2-(4-Chloro-2-formylphenoxy)acetic acid
AA001JDW | MFCD01743493
1446237-40-6
1446237-40-6
5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one
AA001JSJ | MFCD29044862
144873-99-4
144873-99-4
2-(6-Bromopyridin-3-yl)acetonitrile
AA001K7D | MFCD08706175
Submit
© 2017 AA BLOCKS, INC. All rights reserved.